[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO995406D0 - Farmasöytiske sammensetninger av tizoksanid og nitazoksanid - Google Patents

Farmasöytiske sammensetninger av tizoksanid og nitazoksanid

Info

Publication number
NO995406D0
NO995406D0 NO995406A NO995406A NO995406D0 NO 995406 D0 NO995406 D0 NO 995406D0 NO 995406 A NO995406 A NO 995406A NO 995406 A NO995406 A NO 995406A NO 995406 D0 NO995406 D0 NO 995406D0
Authority
NO
Norway
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NO995406A
Other languages
English (en)
Other versions
NO995406L (no
NO313983B1 (no
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995406(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of NO995406D0 publication Critical patent/NO995406D0/no
Publication of NO995406L publication Critical patent/NO995406L/no
Publication of NO313983B1 publication Critical patent/NO313983B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19995406A 1997-05-07 1999-11-04 Farmasöytiske sammensetninger av tizoksanid og nitazoksanid NO313983B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (3)

Publication Number Publication Date
NO995406D0 true NO995406D0 (no) 1999-11-04
NO995406L NO995406L (no) 2000-01-04
NO313983B1 NO313983B1 (no) 2003-01-13

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19995406A NO313983B1 (no) 1997-05-07 1999-11-04 Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
NO20021832A NO335781B1 (no) 1997-05-07 2002-04-18 Farmasøytiske sammensetninger av tizoksanid og nitazoksanid

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20021832A NO335781B1 (no) 1997-05-07 2002-04-18 Farmasøytiske sammensetninger av tizoksanid og nitazoksanid

Country Status (35)

Country Link
EP (2) EP1222921B1 (no)
JP (1) JP3739802B2 (no)
KR (2) KR100576646B1 (no)
CN (2) CN1158074C (no)
AP (1) AP1103A (no)
AR (1) AR057242A2 (no)
AT (2) ATE281166T1 (no)
AU (1) AU740022B2 (no)
BG (2) BG109365A (no)
BR (1) BR9808722A (no)
CA (2) CA2418634C (no)
CZ (2) CZ298269B6 (no)
DE (2) DE69827417T2 (no)
DK (2) DK1222921T3 (no)
EA (2) EA002908B1 (no)
EE (1) EE04870B1 (no)
ES (2) ES2232687T3 (no)
GE (1) GEP20032970B (no)
HK (1) HK1025907A1 (no)
HU (1) HU229641B1 (no)
IL (2) IL155799A (no)
IS (1) IS2087B (no)
LV (1) LV12492B (no)
ME (1) ME00530B (no)
NO (2) NO313983B1 (no)
NZ (2) NZ500149A (no)
OA (1) OA11169A (no)
PL (1) PL193275B1 (no)
PT (2) PT1222921E (no)
RO (1) RO120605B1 (no)
SI (1) SI20149B (no)
SK (2) SK283946B6 (no)
TR (1) TR199902733T2 (no)
UA (2) UA57079C2 (no)
WO (1) WO1998050035A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
US8633230B2 (en) * 2006-01-09 2014-01-21 Jean-Francois Rossignol Viral hepatitis treatment
CN107260695A (zh) * 2009-02-13 2017-10-20 罗马克实验室有限公司 硝唑尼特的控制释放药物剂型
WO2010132404A1 (en) 2009-05-12 2010-11-18 Romark Laboratories L.C. Haloalkyl heteroaryl benzamide compounds
EP2445349B1 (en) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Compounds and methods for treating influenza
EP2808019B1 (en) 2012-01-27 2019-09-25 Siegfried Rhein S.A. De C.V. Improved nitazoxanide composition and preparation method thereof
KR20170081228A (ko) * 2014-11-11 2017-07-11 로마크 레버러토리즈, 엘.씨. 티족사나이드, 그의 유사체 또는 염의 전구 약물을 이용한 치료 조성물 및 방법
MX2020008017A (es) 2018-02-02 2020-12-03 Ripple Therapeutics Corp Formulaciones de vidrio y usos de las mismas.
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen

Also Published As

Publication number Publication date
SK283946B6 (sk) 2004-05-04
NO20021832L (no) 2000-01-04
JP2001503067A (ja) 2001-03-06
HUP0003330A3 (en) 2002-10-28
CN1552322A (zh) 2004-12-08
CZ391199A3 (cs) 2000-07-12
HUP0003330A2 (hu) 2001-05-28
SI20149A (sl) 2000-08-31
DE69809928D1 (de) 2003-01-16
ATE281166T1 (de) 2004-11-15
NO20021832D0 (no) 2002-04-18
AU740022B2 (en) 2001-10-25
IL155799A0 (en) 2003-12-23
TR199902733T2 (xx) 2000-03-21
SI20149B (en) 2001-08-31
EP1005342A1 (en) 2000-06-07
ES2150404T1 (es) 2000-12-01
CA2418634A1 (en) 1998-11-12
NZ513881A (en) 2002-10-25
EE9900578A (et) 2000-08-15
IS2087B (is) 2006-03-15
DE69809928T2 (de) 2003-04-24
IL155799A (en) 2004-08-31
CZ298269B6 (cs) 2007-08-08
JP3739802B2 (ja) 2006-01-25
UA74388C2 (uk) 2005-12-15
GEP20032970B (en) 2003-05-27
KR100426657B1 (ko) 2004-04-13
EA002920B1 (ru) 2002-10-31
EP1222921B1 (en) 2004-11-03
BG109365A (en) 2006-08-31
KR20010020322A (ko) 2001-03-15
DE69827417D1 (de) 2004-12-09
BG103958A (en) 2000-07-31
KR20040004544A (ko) 2004-01-13
NO335781B1 (no) 2015-02-16
ATE228839T1 (de) 2002-12-15
LV12492A (en) 2000-06-20
BR9808722A (pt) 2000-07-11
CN1158074C (zh) 2004-07-21
CN100515420C (zh) 2009-07-22
OA11169A (en) 2003-04-25
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
DE69827417T2 (de) 2005-10-27
IL132516A (en) 2003-12-10
EP1005342B1 (en) 2002-12-04
NO995406L (no) 2000-01-04
NO313983B1 (no) 2003-01-13
DK1222921T3 (da) 2005-03-07
EP1222921A1 (en) 2002-07-17
NZ500149A (en) 2001-11-30
HU229641B1 (en) 2014-03-28
EP1005342A4 (en) 2001-02-07
WO1998050035A1 (en) 1998-11-12
PL193275B1 (pl) 2007-01-31
AR057242A2 (es) 2007-11-21
ME00530B (me) 2011-10-10
KR100576646B1 (ko) 2006-05-08
PL336805A1 (en) 2000-07-17
EA002908B1 (ru) 2002-10-31
UA57079C2 (uk) 2003-06-16
EA200100956A1 (ru) 2002-02-28
ES2150404T3 (es) 2003-07-01
LV12492B (en) 2001-01-20
IS5223A (is) 1999-10-19
BG64973B1 (bg) 2006-11-30
EE04870B1 (et) 2007-08-15
HK1025907A1 (en) 2000-12-01
CA2288003C (en) 2003-10-21
CN1255060A (zh) 2000-05-31
EA199901012A1 (ru) 2000-08-28
IL132516A0 (en) 2001-03-19
DK1005342T3 (da) 2003-03-24
PT1005342E (pt) 2003-02-28
AU7289598A (en) 1998-11-27
RO120605B1 (ro) 2006-05-30
CZ298270B6 (cs) 2007-08-08
PT1222921E (pt) 2005-02-28
SK283947B6 (sk) 2004-05-04
SK151199A3 (en) 2000-07-11
ES2232687T3 (es) 2005-06-01
AP1103A (en) 2002-09-04
CA2288003A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
NO984094L (no) Utladningsreaktor og anvendelse av samme
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HU9800147D0 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
NO20021832D0 (no) Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
BR9509688A (pt) Composto e composição farmacêutica
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
EP0996441A4 (en) PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
BR9605220A (pt) Gonadotropinas e composiçao farmacêutica
BR9505130A (pt) Composto e composiçao farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use
DK1014951T3 (da) Farmaceutisk coatingssammensætning og fremgangsmåde til anvendelse
BR1101151A (pt) Compostos e composição farmacêutica
ZA99887B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
ZA995006B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
NO973261L (no) Fremgangsmåte og farmasöytiske blandinger utnyttende desmetylselegilin
BR1100838A (pt) Composto e composição farmacêutica

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees